These findings expose a clear demarcation between the realms of chance and necessity at different hierarchical levels. At the level of biochemical phenotype, and even at the level of functional mechanism, evolutionary changes are highly predictable. At the amino acid level, in contrast, predictability breaks down.
In addition to the many-to-one mapping of genotype to phenotype, the phylogenetic distribution of affinity-enhancing parallel substitutions suggests another possible explanation for the limited contribution of such substitutions to convergent functional changes in the Hbs of distantly related species. The most striking functional parallelism at the amino acid level was concentrated in the hummingbird clade. Replicated G83S substitutions contributed to convergent increases in Hb-O 2 affinity in multiple high-altitude hummingbird species (table S5 and fig. S4 ) (16) , and a convergent substitution at the same site (N83S) occurred in one other (nonhummingbird) highaltitude species: the black-throated flowerpiercer, Diglossa brunneiventris. One possible explanation for this phylogenetically concentrated pattern of parallelism is that the mutation's phenotypic effect is conditional on genetic background, so the same mutation produces different effects in different species.
To test this hypothesis, we used ancestral sequence reconstruction in combination with site-directed mutagenesis to test the effect of b83 substitutions in a set of distinct genetic backgrounds. We first resurrected HbA of the common ancestor of hummingbirds ("Anc hummingbird") (figs. S5 to S7), and we confirmed that G83S has a significant affinity-enhancing effect on this ancestral genetic background (Fig. 3A) . This result is consistent with the affinity-enhancing effect of G83S in numerous descendant lineages of highaltitude hummingbirds (table S5 and fig. S4 ). In similar fashion, we resurrected HbA of the common ancestor of the high-and low-altitude flowerpiercers ("Anc flowerpiercer") to test the effect of N83S ( fig. S7) . Hbs of the two flowerpiercers differed at two sites because of substitutions in the D. brunneiventris lineage (V67A in a A -globin, in addition to N83S in b A -globin; Fig. 1 ). We therefore synthesized a total of four recombinant Hb mutants, representing each possible genotypic combination of the two substituted sites, to measure the relative contributions of V67A and N83S to the evolved increase in Hb-O 2 affinity in D. brunneiventris (table S2 and fig. S4 ). The tests showed that both mutations increased Hb-O 2 affinity in an additive fashion (Fig. 3B) . We then engineered the same N83S mutation into resurrected ancestral Hbs representing two far more ancient nodes in the avian phylogeny: the reconstructed common ancestor of Neoaves ("Anc Neoaves") and the common ancestor of all extant birds ("Anc Neornithes") ( Fig. 3C and figs. S5, S7, S8, and S9). In contrast to the highly significant effects of N/G83S in hummingbird and flowerpiercer Hbs, N83S produced no detectable effect in Anc Neoaves or Anc Neornithes (Fig. 3D  and table S6 ). The ancestral hummingbird and flowerpiercer Hbs contained 18 and 32 amino acid states, respectively, that were not present in Anc Neornithes ( fig. S7 ), representing net sequence differences that accumulated over a~100-millionyear time period. The context-dependent effects of N/G83S indicate that lineage-specific substitutions in the ancestry of hummingbirds and flowerpiercers produced a genetic background in which mutations at b83 could contribute to an adaptive increase in Hb-O 2 affinity. This adaptive solution was apparently not an option in the deeper ancestry of birds and may also represent a precluded possibility in contemporary, highaltitude members of other avian lineages.
These findings reveal a potentially important role of contingency in adaptive protein evolution. In different species that are adapting to the same selection pressure, the set of possible amino acids at a given site that have unconditionally beneficial effects may be contingent on the set of antecedent substitutions that have independently accumulated in the history of each lineage. Consequently, possible options for adaptive change in one species may be foreclosed options in other species.
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This work was funded by grants from the U.S. NIH (HL087216), the U. Methyl-coenzyme M reductase (MCR) is the key enzyme of methanogenesis and anaerobic methane oxidation. The activity of MCR is dependent on the unique nickel-containing tetrapyrrole known as coenzyme F430. We used comparative genomics to identify the coenzyme F430 biosynthesis (cfb) genes and characterized the encoded enzymes from Methanosarcina acetivorans C2A. The pathway involves nickelochelation by a nickel-specific chelatase, followed by amidation to form Ni-sirohydrochlorin a,c-diamide. Next, a primitive homolog of nitrogenase mediates a six-electron reduction and g-lactamization reaction before a Mur ligase homolog forms the six-membered carbocyclic ring in the final step of the pathway. These data show that coenzyme F430 can be synthesized from sirohydrochlorin using Cfb enzymes produced heterologously in a nonmethanogen host and identify several targets for inhibitors of biological methane formation.
M ethanogenic archaea are a major player in the global carbon cycle, producing nearly 1 billion metric tons of methane annually (1, 2) . The terminal step of methanogenesis is catalyzed by methylcoenzyme M reductase (MCR) and involves the conversion of coenzyme B (CoB-SH) and methylcoenzyme M (MeS-CoM) to the mixed heterodisulfide CoB-S-S-CoM and methane (3) (Fig. 1) .
MCR uses the unique nickel-containing tetrapyrrole coenzyme F430 to carry out its catalytic function (4) (Fig. 1) . Recently, anaerobic methanotrophic archaea (ANME) have been shown to contain a homolog of MCR and catalyze the anaerobic oxidation of methane (AOM) (5) . AOM is thought to operate, at least in part, as the reverse of methanogenesis, with MCR catalyzing the critical first step in the pathway, the activation of methane with CoB-S-S-CoM (6) .
There is great interest in strategies to convert methane to liquid fuel or other more easily transported commodity chemicals. The development of a bioconversion process for methane that uses AOM is an attractive solution (7); however, efforts to engineer industrially viable anaerobic methanotrophic strains are hindered by the lack of genetic and biochemical information about the biosynthesis of coenzyme F430 and the formation of holo-MCR.
At present, the genomes of >60 species of methanogenic archaea have been sequenced. We searched these genomes for homologs of known chelatase genes, whose products are responsible for metal ion insertion into tetrapyrrolic cofactors (8) . Analysis of the genomic contexts of the chelatase homologs, along with knowledge of the chemistry required for the conversion of known precursors of C2 and C7 methylated tetrapyrroles to coenzyme F430 (9), led to the identification of five genes, conserved in all methanogens, that are potentially involved in coenzyme F430 biosynthesis ( Fig. 1 and fig. S1 ). These genes are also present in the genome of an ANME-2d strain (Candidatus Methanoperedens nitroreducens) (fig. S1) (10) .
Included among these genes are homologs of the genes for sirohydrochlorin cobaltochelatase (cbiX S ) and cobyrinic acid a,c-diamide synthetase (cbiA2), which are involved in the biosynthesis of cobalamin (11) . Also present are homologs of the nitrogenase genes nifD and nifH, which (together with nifK) encode subunits of the two-component metalloenzyme responsible for the adenosine triphosphate (ATP)-dependent reduction of dinitrogen to ammonia (nitrogen fixation) (12) . Nitrogenase is structurally and functionally related to the dark-operative protochlorophyllide oxidoreductase (DPOR), which is involved in chlorophyll and bacteriochlorophyll biosynthesis (13) . However, methanogens are not photosynthetic microorganisms, and not all methanogens are diazotrophic (i.e., fix nitrogen). The presence of the nifD (methanogenesis marker 13) and nifH homologs in all methanogens was noted previously, and these genes were found to be constitutively expressed and the encoded proteins shown to associate with one another (14, 15) . Methanogenesis markers are found in prokaryotic genomes if, and only if, the species is an archaeal methanogen. The fifth gene is homologous to murD, a gene that encodes an ATP-dependent Mur ligase (uridine diphosphate N-acetylmuramoyl-Lalanine:D-glutamate ligase) involved in bacterial cell wall biosynthesis (16) . Each of these genes (except for cbiA2) was targeted in a genome-wide transposon mutagenesis experiment in the methanogen Methanococcus maripaludis and were all found to be essential (17) .
We cloned the identified genes from Methanosarcina acetivorans C2A and ligated them into expression vectors for heterologous production of the encoded enzymes in Escherichia coli. The enzymes were then purified as N-terminal His 6 -tagged fusion proteins and systematically tested for activity (supplementary materials and fig. S2 ).
We tested the "small" sirohydrochlorin cobaltochelatase (CbiX S ) homolog, which we designate as CfbA, for nickelochelatase activity with enzymatically prepared sirohydrochlorin and dihydrosirohydrochlorin (precorrin 2) (18). Precorrin 2 is the immediate biosynthetic precursor of sirohydrochlorin and is two-electrons more reduced than the latter (19) . Because coenzyme F430 is a highly reduced tetrapyrrole, we reasoned that precorrin 2 might be the substrate of CfbA. However, no nickel chelation activity was observed with precorrin 2 under any of the assay conditions tested. We therefore turned our attention to sirohydrochlorin. We observed that, unlike other divalent transition metal ions (e.g., Fe 2+ , Co 2+ , and Zn 2+ ), there is no evidence of rapid, nonenzymatic insertion of Ni 2+ into sirohydrochlorin under our assay conditions. However, in the presence of both Ni 2+ and CfbA (and only if the His 6 -tag of CfbA was first removed by thrombin cleavage), the reaction mixture changed from the bright magenta color characteristic of sirohydrochlorin to a deep purple (Fig. 2 and fig. S3 ). Analysis of the reaction mixtures by reversed-phase high-performance liquid chromatography (HPLC) showed the near-complete conversion of sirohydrochlorin (which has a retention time of 16.1 min) to a new compound that elutes at 20.2 min (Fig. 2) The addition of the cobyrinic acid a,c-diamide synthetase homolog (CfbB) to the reaction mixture enhanced the yield of Ni-sirohydrochlorin ( fig. S4 ). Intermediates in tetrapyrrole biosynthesis often remain tightly bound to their cognate enzyme and are thought to be transferred to the next enzyme in the pathway by substrate channeling (21) . Therefore, tetrapyrrole biosynthetic enzymes often exhibit substantial product inhibition, which can be relieved by the addition of the subsequent pathway enzyme in vitro. This suggests that CfbB acts next in the pathway and will accept Ni-sirohydrochlorin as a substrate.
CbiA is a glutamine amidotransferase that catalyzes the ATP-dependent amidation of the a-and c-carboxylic acid moieties of cobyrinic acid in the cobalamin biosynthetic pathway (22) . Coenzyme F430 also has amide functional groups at these positions, and we reasoned that CfbB was a Ni-sirohydrochlorin a,c-diamide synthetase. UV-visible spectrum to that of Ni-sirohydrochlorin (l max = 386 and 590 nm)-although its HPLC retention time was shorter by 3 min (17.0 min) and its observed mass was lighter by 1.97 atomic mass units, with a m /z identical to the [M + H] + calc for Ni-sirohydrochlorin a,c-diamide (Fig.  2 and fig. S5 ). The yield of Ni-sirohydrochlorin a,c-diamide could again be enhanced by the addition of the subsequent enzyme in the pathway (CfbCD, a complex of CfbC and CfbD), without the reductant required for its activity (vide infra), to alleviate product inhibition (fig. S6) . The inclusion of an ATP regeneration system [phosphoenolpyruvate (PEP) and pyruvate kinase (PK)] also helped to drive the CfbB reaction forward ( fig. S6) .
Two distinctive structural features of coenzyme F430 are the presence of the g-lactam E ring and the carbocyclic F ring, which form from the c-acetamide and g-propionate side chains of Ni-sirohydrochlorin a,c-diamide, respectively. The high degree of similarity between the UVvisible spectra of Ni-sirohydrochlorin and Nisirohydrochlorin a,c-diamide indicates that the product of the CfbB reaction lacks the g-lactam ring and contains the free amide (Fig. 2) .
When the purified CfbCD complex was included in the CfbB reaction, along with the reductant sodium dithionite, ATP, and an ATP regeneration system (all of which were required for activity), the solution changed from the deep purple color characteristic of Ni-sirohydrochlorin a,c-diamide to a pale yellow. Analysis of the reaction mixture by HPLC showed the disappearance of the 17.0-min peak and the formation of a new peak with a retention time of 8.1 min (Fig. 2  and fig. S7) (Fig. 2) . This intermediate was identical in structure to coenzyme F430, except for the presence of the g-propionate side chain instead of the F ring. Thus, CfbCD effects both the six-electron reduction of the tetrahydroporphyrin ring system of Ni-sirohydrochlorin a,c-diamide and the g-lactamization of its c-acetamide side chain to form the E ring.
As noted above, CfbC is homologous to the Fe protein (NifH) and CfbD to the NifD subunit of the MoFe protein (NifDK) of nitrogenase, which catalyzes an eight-electron reduction of N 2 to NH 3 and two protons to H 2 (12) . The nif D and nif K genes are proposed to have arisen from the paralogous gene duplication and divergence of an ancient shared precursor (24) . The nitrogenase homolog DPOR is an analogous two-component system (BchH and BchNB) with similar structural topology and catalyzes a two-electron reduction of the C17=C18 double bond of protochlorophyllide to form chlorophyllide a in the chlorophyll biosynthetic pathway (13) . Unlike nitrogenase and DPOR, the Nisirohydrochlorin a,c-diamide reductive cyclase contains a homomeric MoFe protein homolog (CfbD) and is thus representative of an earlybranching lineage of this enzyme family. A study of the molecular phylogeny of nitrogenase homologs placed the ancestral cfbC and cf bD genes in the last common ancestor of modern organisms and positioned them basal to the emergence of the groups involved in nitrogen fixation and the biosynthesis of photosynthetic pigments (14) .
The last enzyme encoded by the cf b cluster, CfbE, is homologous to an ATP-dependent Mur ligase. Mur ligases use ATP to activate a carboxylic acid group as an acyl-phosphate for nonribosomal peptide bond formation during the biosynthesis of peptidoglycan (25) . We reasoned that CfbE could use similar chemistry to activate the g-propionate side chain for intramolecular C-C bond formation to produce the carbocyclic F ring and thus function as a coenzyme F430 synthetase. As expected, addition of CfbE to reaction mixtures containing 15,17 3 -seco-F430-17 3 -acid resulted in the production of a new compound in low yield, which had an identical HPLC retention time (7.6 min), UV-visible spectrum, and isotopic mass distribution to authentic coenzyme F430 ( fig. S8) .
We hypothesized that the low yield of coenzyme F430 was due to product inhibition of the CfbE reaction. The mcr gene cluster encoding the a, b, and g subunits of MCR, which has been identified previously and is distinct from the cf b cluster, contains two genes, mcrC and mcrD, of unknown function (26) . Recently, McrC was identified as a component of a large reductase complex capable of reducing coenzyme F430 to the Ni 1+ form, and thus it may play a role in MCR activation (27) . McrD has been shown to physically interact with MCR through coprecipitation experiments, though it is not required for in vitro MCR activity (28) . We postulated that McrD may function as a chaperone protein that could bind coenzyme F430 and deliver it to apo-MCR. We therefore cloned mcrD from M. acetivorans C2A and expressed and purified the encoded protein to determine whether it was capable of accepting coenzyme F430 from CfbE and alleviating the observed inhibition. Consistent with this expectation, nearly full conversion of 15,17 3 -seco-F430-17 3 -acid to coenzyme F430 was observed when McrD was included in the reaction mixtures (Fig. 2 and figs. S9 and S10) .
Each of the identified coenzyme F430 biosynthetic enzymes represents a new target for inhibitors of methanogenesis. The data show that these enzymes are sufficient for the synthesis of coenzyme F430 from the common tetrapyrrolic intermediate sirohydrochlorin and can be produced in an active form in E. coli. Furthermore, if McrD is confirmed as a coenzyme F430-binding protein that chaperones the coenzyme to MCR, this protein will also be required for the heterologous production of holo-MCR. Taken together, these findings set the stage for metabolic engineering efforts using MCR for anaerobic methane conversion.
